Otsuka Canada Pharmaceutical Revenue and Competitors

Saint-Laurent,, QC CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Otsuka Canada Pharmaceutical's estimated annual revenue is currently $30.1M per year.(i)
  • Otsuka Canada Pharmaceutical's estimated revenue per employee is $201,000

Employee Data

  • Otsuka Canada Pharmaceutical has 150 Employees.(i)
  • Otsuka Canada Pharmaceutical grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M167%N/AN/A
#2
$30.2M1501%N/AN/A
#3
$10.7M1005%$39.7MN/A
#4
$104.3M51922%N/AN/A
#5
$47.8M238N/AN/AN/A
#6
$15.5M775%N/AN/A
#7
$395.8M19697%N/AN/A
#8
$187.3M9326%N/AN/A
#9
$361.6M17996%N/AN/A
#10
$27.5M1370%N/AN/A
Add Company

What Is Otsuka Canada Pharmaceutical?

Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, cardio-renal, and oncology. OCPI is dedicated to improving patients' health and the quality of human life. We have recently become aware of fraudulent job offers being made by persons alleging to be acting on behalf of Otsuka. If you are suspicious of a communication received through this site please see the Notice that appears on our company website and refer to the available job postings on our Careers page.

keywords:N/A

N/A

Total Funding

150

Number of Employees

$30.1M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Otsuka Canada Pharmaceutical News

2022-04-17 - Irony Point Chiefs on the Potential for More ‘I Think You Should Leave,’ Marvel Podcast and Steering Clear of M&A (for Now)

Otsuka Canada Pharmaceutical Inc. (OCPI) today announced that Health Canada has approved Tavneos® (avacopan), an orally administered...

2022-04-17 - Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of TAVNEOS® (avacopan) for ANCA-Associated Vasculitis

Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of TAVNEOS® (avacopan) for ANCA-Associated Vasculitis.

2022-04-17 - Otsuka Canada Pharmaceutical Inc. announces Health Canada ...

Otsuka Pharmaceutical is a wholly owned subsidiary of Otsuka Holdings Co., Ltd., based in Tokyo, Japan. The Otsuka group of companies employs...